{"<h2>Summary</h2><h3>Background</h3>": [0], "Antimicrobial": [1], "resistance": [2, 326, 364, 382], "(AMR)": [3], "poses": [4], "a": [5, 142, 150, 161, 167, 499], "major": [6], "threat": [7], "to": [8, 52, 63, 112, 149, 160, 171, 204, 274, 311, 325, 327, 409, 434, 525, 529, 544, 568, 577], "human": [9, 584], "health": [10, 585], "around": [11, 504], "the": [12, 18, 45, 164, 177, 251, 275, 282, 315, 320, 369, 477, 482, 493, 505, 508, 515, 520, 566, 608], "world.": [13], "Previous": [14], "publications": [15], "have": [16], "estimated": [17, 56, 195, 292, 319], "effect": [19], "of": [20, 27, 49, 115, 137, 145, 155, 166, 174, 180, 184, 284, 481, 485, 492, 495, 502, 517, 551, 581, 597], "AMR": [21, 50, 68, 116, 205, 225, 300, 410, 418, 435, 497, 518], "on": [22, 199, 207, 227], "incidence,": [23], "deaths,": [24], "hospital": [25, 90], "length": [26], "stay,": [28], "and": [29, 58, 64, 72, 79, 94, 104, 176, 221, 253, 261, 277, 341, 395, 411, 465, 519, 532, 540, 547, 549, 554, 573, 595, 599], "health-care": [30], "costs": [31], "for": [32, 69, 118, 122, 247, 265, 356, 378, 400], "specific": [33], "pathogen\u2013drug": [34, 74, 422, 522], "combinations": [35, 75, 523], "in": [36, 76, 81, 211, 231, 301, 330, 343, 365, 419, 436, 511, 561], "select": [37], "locations.": [38], "To": [39, 471], "our": [40, 285, 472, 579], "knowledge,": [41, 473], "this": [42, 189, 474, 582], "study": [43, 475], "presents": [44], "most": [46, 370], "comprehensive": [47, 479], "estimates": [48, 114, 249, 272], "burden": [51, 117, 197, 484, 516], "date.": [53], "<h3>Methods</h3>": [54], "We": [55, 83, 107, 241, 269], "deaths": [57, 138, 147, 158, 202, 222, 296, 309, 336, 347, 361, 379, 407, 415, 432], "disability-adjusted": [59], "life-years": [60], "(DALYs)": [61], "attributable": [62, 148, 159, 203, 310, 324, 408, 433], "associated": [65, 187, 223, 297, 362, 380, 416], "with": [66, 124, 188, 224, 298, 363, 381, 417, 507], "bacterial": [67, 299, 312], "23": [70], "pathogens": [71, 377], "88": [73], "204": [77], "countries": [78], "territories": [80], "2019.": [82, 420], "obtained": [84], "data": [85, 559, 574], "from": [86], "systematic": [87], "literature": [88], "reviews,": [89], "systems,": [91, 93], "surveillance": [92], "other": [95], "sources,": [96], "covering": [97], "471": [98], "million": [99, 294, 305, 360, 413], "individual": [100], "records": [101], "or": [102, 182], "isolates": [103], "7585": [105], "study-location-years.": [106], "used": [108], "predictive": [109, 267, 286], "statistical": [110, 287], "modelling": [111], "produce": [113], "all": [119, 213, 233], "locations,": [120], "including": [121, 303], "locations": [123], "no": [125, 239], "data.": [126, 496], "Our": [127], "approach": [128], "can": [129], "be": [130, 328], "divided": [131], "into": [132], "five": [133], "broad": [134], "components:": [135], "number": [136], "where": [139], "infection": [140, 186, 538], "played": [141], "role,": [143], "proportion": [144, 154], "infectious": [146, 152, 156, 372], "given": [151, 162, 168], "syndrome,": [153], "syndrome": [157], "pathogen,": [163], "percentage": [165], "pathogen": [169], "resistant": [170], "an": [172, 185, 208, 228, 291, 490], "antibiotic": [173], "interest,": [175], "excess": [178], "risk": [179], "death": [181, 322, 503], "duration": [183], "resistance.": [190], "Using": [191], "these": [192], "components,": [193], "we": [194, 318], "disease": [196], "based": [198], "two": [200], "counterfactuals:": [201], "(based": [206, 226], "alternative": [209, 229], "scenario": [210, 230], "which": [212, 232], "drug-resistant": [214, 234, 450], "infections": [215, 235, 354], "were": [216, 236, 263, 290, 398], "replaced": [217, 237], "by": [218, 238, 386, 607], "drug-susceptible": [219], "infections),": [220], "infection).": [240], "generated": [242], "95%": [243], "uncertainty": [244], "intervals": [245], "(UIs)": [246], "final": [248, 271], "as": [250, 487, 489], "25th": [252], "975th": [254], "ordered": [255], "values": [256], "across": [257], "1000": [258], "posterior": [259], "draws,": [260], "models": [262], "cross-validated": [264], "out-of-sample": [266], "validity.": [268], "present": [270], "aggregated": [273], "global": [276, 483], "regional": [278, 316], "level.": [279], "<h3>Findings</h3>": [280], "On": [281], "basis": [283], "models,": [288], "there": [289], "4\u00b795": [293], "(3\u00b762\u20136\u00b757)": [295], "2019,": [302, 366, 437], "1\u00b727": [304], "(95%": [306], "UI": [307], "0\u00b7911\u20131\u00b771)": [308], "AMR.": [313], "At": [314], "level,": [317], "all-age": [321], "rate": [323], "highest": [329, 509], "western": [331], "sub-Saharan": [332], "Africa,": [333], "at": [334, 345], "27\u00b73": [335], "per": [337, 349], "100": [338, 350, 430], "000": [339, 402, 431, 445], "(20\u00b79\u201335\u00b73),": [340], "lowest": [342], "Australasia,": [344], "6\u00b75": [346], "(4\u00b73\u20139\u00b74)": [348], "000.": [351], "Lower": [352], "respiratory": [353], "accounted": [355], "more": [357, 428, 440], "than": [358, 429], "1\u00b75": [359], "making": [367, 530], "it": [368, 526], "burdensome": [371], "syndrome.": [373], "The": [374], "six": [375, 439], "leading": [376, 500, 521], "(<i>Escherichia": [383], "coli</i>,": [384, 461], "followed": [385], "<i>Staphylococcus": [387], "aureus,": [388], "Klebsiella": [389], "pneumoniae,": [390, 392], "Streptococcus": [391], "Acinetobacter": [393], "baumannii</i>,": [394], "<i>Pseudomonas": [396], "aeruginosa</i>)": [397], "responsible": [399], "929": [401], "(660": [403], "000\u20131": [404], "270": [405], "000)": [406], "3\u00b757": [412], "(2\u00b762\u20134\u00b778)": [414], "One": [421], "combination,": [423], "meticillin-resistant": [424], "<i>S": [425], "aureus</i>,": [426], "caused": [427, 442], "while": [438], "each": [441], "50": [443], "000\u2013100": [444], "deaths:": [446], "multidrug-resistant": [447], "excluding": [448], "extensively": [449], "tuberculosis,": [451], "third-generation": [452, 466], "cephalosporin-resistant": [453, 467], "<i>E": [454], "coli,": [455], "carbapenem-resistant</i>": [456], "A": [457], "baumannii,": [458], "<i>fluoroquinolone-resistant": [459], "E": [460], "carbapenem-resistant": [462], "<i>K": [463, 468], "pneumoniae</i>,": [464], "pneumoniae</i>.": [469], "<h3>Interpretation</h3>": [470], "provides": [476], "first": [478], "assessment": [480], "AMR,": [486], "well": [488], "evaluation": [491], "availability": [494], "is": [498, 527], "cause": [501], "world,": [506], "burdens": [510], "low-resource": [512], "settings.": [513], "Understanding": [514], "contributing": [524], "crucial": [528], "informed": [531], "location-specific": [533], "policy": [534], "decisions,": [535], "particularly": [536], "about": [537], "prevention": [539], "control": [541], "programmes,": [542], "access": [543], "essential": [545], "antibiotics,": [546], "research": [548], "development": [550], "new": [552], "vaccines": [553], "antibiotics.": [555], "There": [556], "are": [557], "serious": [558], "gaps": [560], "many": [562], "low-income": [563], "settings,": [564], "emphasising": [565], "need": [567], "expand": [569], "microbiology": [570], "laboratory": [571], "capacity": [572], "collection": [575], "systems": [576], "improve": [578], "understanding": [580], "important": [583], "threat.": [586], "<h3>Funding</h3>": [587], "Bill": [588], "&": [589], "Melinda": [590], "Gates": [591], "Foundation,": [592], "Wellcome": [593], "Trust,": [594], "Department": [596], "Health": [598], "Social": [600], "Care": [601], "using": [602], "UK": [603], "aid": [604], "funding": [605], "managed": [606], "Fleming": [609], "Fund.": [610]}